| Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing–induced congestive heart failure D Li, K Shinagawa, L Pang, TK Leung, S Cardin, Z Wang, S Nattel Circulation 104 (21), 2608-2614, 2001 | 845 | 2001 |
| Comprehensive translational assessment of human-induced pluripotent stem cell derived cardiomyocytes for evaluating drug-induced arrhythmias K Blinova, J Stohlman, J Vicente, D Chan, L Johannesen, ... Toxicological Sciences 155 (1), 234-247, 2016 | 91 | 2016 |
| Tissue‐specific expression of two human Cav1.2 isoforms under the control of distinct 5′ flanking regulatory elements L Pang, G Koren, Z Wang, S Nattel FEBS letters 546 (2-3), 349-354, 2003 | 58 | 2003 |
| International multisite study of human-induced pluripotent stem cell-derived cardiomyocytes for drug proarrhythmic potential assessment K Blinova, Q Dang, D Millard, G Smith, J Pierson, L Guo, M Brock, HR Lu, ... Cell reports 24 (13), 3582-3592, 2018 | 45 | 2018 |
| Characterization of a putative insulin-responsive element and its binding protein (s) in rat angiotensinogen gene promoter: regulation by glucose and insulin X Chen, SL Zhang, L Pang, JG Filep, SS Tang, JR Ingelfinger, JSD Chan Endocrinology 142 (6), 2577-2585, 2001 | 38 | 2001 |
| Vascular smooth muscle-specific knockdown of the noncardiac form of the L-type calcium channel by microRNA-based short hairpin RNA as a potential antihypertensive therapy SW Rhee, JR Stimers, W Wang, L Pang Journal of Pharmacology and Experimental Therapeutics 329 (2), 775-782, 2009 | 34 | 2009 |
| Evaluation of batch variations in induced pluripotent stem cell-derived human cardiomyocytes from 2 major suppliers J Huo, A Kamalakar, X Yang, B Word, N Stockbridge, B Lyn-Cook, L Pang Toxicological Sciences 156 (1), 25-38, 2016 | 27 | 2016 |
| Vascular-Specific Increase in Exon 1b-Encoded CaV1.2 Channels in Spontaneously Hypertensive Rats W Wang, N Saada, B Dai, L Pang, P Palade American journal of hypertension 19 (8), 823-831, 2006 | 19 | 2006 |
| Characterization of the cardiac KCNE1 gene promoter Z Mustapha, L Pang, S Nattel Cardiovascular research 73 (1), 82-91, 2007 | 17 | 2007 |
| ATP-binding cassette genes genotype and expression: a potential association with pancreatic cancer development and chemoresistance? L Pang, B Word, J Xu, H Wang, G Hammons, SM Huang, B Lyn-Cook Gastroenterology research and practice 2014, 2014 | 14 | 2014 |
| MicroRNA-mediated maturation of human pluripotent stem cell-derived cardiomyocytes: Towards a better model for cardiotoxicity? MC White, L Pang, X Yang Food and Chemical Toxicology 98, 17-24, 2016 | 11 | 2016 |
| Angiotensin II upregulates Cav1. 2 protein expression in cultured arteries via endothelial H2O2 production W Wang, L Pang, P Palade Journal of vascular research 48 (1), 67-78, 2011 | 11 | 2011 |
| Angiotensin II causes endothelial-dependent increase in expression of CaV1. 2 protein in cultured arteries W Wang, L Pang, P Palade European journal of pharmacology 599 (1-3), 117-120, 2008 | 10 | 2008 |
| High-conductance, Ca2+-activated K+ channels: altered expression profiles in aging and cardiovascular disease L Pang, NJ Rusch Molecular interventions 9 (5), 230, 2009 | 6 | 2009 |
| Molecular mechanism (s) of insulin action on the expression of the angiotensinogen gene in kidney proximal tubular cells XH Wu, X Chen, SL Zhang, L Pang, C To, TT Wang, TC Hohman, JG Filep, ... Journal of the Renin-Angiotensin-Aldosterone System 1 (2), 166-174, 2000 | 6 | 2000 |
| Sex-related differences in drug-induced QT prolongation and torsades de pointes: a new model system with human iPSC-CMs J Huo, F Wei, C Cai, B Lyn-Cook, L Pang Toxicological Sciences 167 (2), 360-374, 2018 | 5 | 2018 |
| Metformin effects on ABCB1 expression and proliferation in pancreatic cancer cell lines with different ABCB1 genotypes/haplotypes BD Lyn-Cook, T Osborne, S Joseph, B Word, L Pang, G Hammons Cancer Research 75 (15 Supplement), 4428-4428, 2015 | 2 | 2015 |
| Fatty Acid-Based Medium Promoted Metabolic Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes C Cai, F Wei, Q Shi, X Yang, DG Strauss, N Stockbridge, L Pang Circulation 138 (Suppl_1), A16287-A16287, 2018 | 1 | 2018 |
| AAV-mediated vascular smooth muscle-specific knockdown of Cav1. 2 as a long-term anti-hypertensive therapy L Pang, S Sonkusare, K Thakali, R Melchert, K Roberto, P Palade The FASEB Journal 23 (1_supplement), 932.4-932.4, 2009 | 1 | 2009 |
| Vascular smooth muscle-specific knockdown of non-cardiac form of L-type calcium channel by shRNA-A potential anti-hypertensive therapy SW Rhee, JR Stimers, W Wang, L Pang Journal of Pharmacology and Experimental Therapeutics, 2009 | 1 | 2009 |
